A European biotech partnered with Morula Health to streamline complex infectious disease medical writing across 15 projects, ensuring continuity, deep AMR expertise, and successful NDA‑ready submissions for a multi‑year global research program.
A European biotech organization sought a long-term partner to support its ambitious infectious disease R&D and clinical documentation needs.
Their mission was clear: deliver high-quality medical and scientific documents to accelerate drug development for AMR research.
The Challenge
They faced a significant challenge: managing a broad range of complex medical writing deliverables across global programs without overburdening the internal teams.
Previous collaborations had resulted in high writer turnover and inconsistent expertise in AMR. They needed a partner who could provide continuity, deep therapeutic knowledge, and operational efficiency for a multi-year program culminating in regulatory approval.
The Solution
We assigned a dedicated pod of passionate writers specializing in infectious diseases, ensuring familiarity and efficiency. The client’s satisfaction with the initial project led to work spanning 15 projects over three years.
From clinical trial protocols and CSRs to manuscripts and regulatory appendices, every document adhered to rigorous QC processes and timelines.
By planning projects in advance, the client was able to work with the same writer continuously, allowing us to streamline workflows while maintaining full transparency and consistency throughout.
Case Study Highlights
– Supported NDA-ready submissions.
– Delivered consistent quality with the same two lead writers.
– Contributed to the successful approval, acknowledged in a Lancet publication.
– Built a partnership rooted in passion for infectious diseases, creating a “rapid response team”.